Hired and Retired: Resignations take industry by surprise
March saw significant changes within leadership roles across the industry, with more than one unexpected resignation.
Both the European Medicines Agency and the US Food and Drug Administration had to contend with finding appointees for significant roles – with one offering continuity and the other requiring a quick leadership turnover.
In the industry itself, Novartis saw a shock departure, as it looks to undertake a transformation of a key subsidiary.
Door open - Getty SasinParaksa FDA, Ned Sharpless Sandoz, Francesco Balestrieri Boehringer Ingelheim, Mehdi Shahidi EMA, Christa Wirthumer-Hoche Allergan, ?